Clinical Trials

13 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT01570296 2023-03-29

BKM120

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02088112 2022-04-04

MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).

56 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02374645 2020-04-24

A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLC

64 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00027625 2018-06-27

Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00372515 2018-01-31

High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations

7 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00310154 2017-05-30

Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

45 enrolled

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00186979 2017-04-26

Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors

34 enrolled

Solid Tumors

NCT02040064 2016-06-09

GEFTREM

27 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00162318 2015-10-28

A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01602289 2015-06-08

A Study of LY2875358 in Japanese Participants With Advanced Cancer

17 enrolled

LymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Lymphoma

NCT00084708 2014-01-13

Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors

53 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005806 2013-06-19

Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00026364 2013-03-21

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer

22 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00039390 2013-01-25

Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors

41 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00040781 2013-01-23

Gefitinib in Treating Children With Refractory Solid Tumors

45 enrolled

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00084786 2013-01-17

Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

NCT00132158 2012-04-17

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

19 enrolled

CNSSarcoma

Glioblastoma, Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma

NCT00083057 2012-03-15

Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

30 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00255489 2011-01-25

A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer

36 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00681967 2010-09-23

IRESSA&H&N

30 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00185835 2010-03-29

Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck

10 enrolled

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00502060 2009-05-14

Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer

65 enrolled

Advanced Tumor

NCT00127829 2009-04-23

AGUS

66 enrolled

Tumor-Agnostic

Neoplasms

NCT00252798 2007-12-19

ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer

44 enrolled